Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Conditions
Non-small Cell Lung Cancer · Histiocytic Neoplasm · Histiocytosis · BRAF Gene Mutation · BRAF V600E · BRAF V600 Mutation · BRAF Mutation-Related Tumors · BRAF · Metastatic Lung Non-Small Cell Carcinoma · Metastatic Lung Cancer · Recurrent Lung Cancer · Recurrent Lung Non-Small Cell Carcinoma · NSCLC · Solid Tumor · Solid Carcinoma · KRAS G12D · KRAS G12V · KRAS Mutation-Related Tumors · NRAS Gene Mutation · Thyroid Cancer · Thyroid Carcinoma · Colorectal Cancer · Colorectal Carcinoma · Recurrent Histiocytic and Dendritic Cell Neoplasm · Brain Metastases · Recurrent NSCLC · KRAS G13C · Acquired Resistance to KRAS G12C Inhibitor · KRAS G12A · KRAS G12F · KRAS G12R · KRAS G13D
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Banner Health- MD Anderson Cancer Center, Gilbert, Arizona, United States
Contact: Principal Investigator (Jiaxin Niu, MD)University of Colorado - Aurora Cancer Center, Aurora, Colorado, United States
Georgetown University Lombardi Cancer Center, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Chul Kim, MD)Dana-Farber Cancer Institute, Boston, Massachusetts, United States
South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids, Michigan, United States
Masonic Cancer Center University of Minnesota, Minneapolis, Minnesota, United States
Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Medical Oncology Clinical Call Center) · MedicalOncologyClinicalCallCenter@dom.wustl.edu · 314-747-1171Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Michael Offin, MD)NEXT Virginia, Fairfax, Virginia, United States
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
National Cancer Center Hospital, Tokyo, Japan